13 28/02/2023 2023-02-28 false false false false false false false false false false true false false true false false false false false false false 2022-03-01 Sage Accounts Production 21.0 - FRS102_2021 xbrli:pure xbrli:shares iso4217:GBP 07464490 2022-03-01 2023-02-28 07464490 2023-02-28 07464490 2022-02-28 07464490 2021-03-01 2022-02-28 07464490 2022-02-28 07464490 core:FurnitureFittingsToolsEquipment 2022-03-01 2023-02-28 07464490 core:NetGoodwill 2022-03-01 2023-02-28 07464490 bus:Director1 2022-03-01 2023-02-28 07464490 core:NetGoodwill 2022-02-28 07464490 core:NetGoodwill 2023-02-28 07464490 core:LandBuildings core:ShortLeaseholdAssets 2022-02-28 07464490 core:FurnitureFittingsToolsEquipment 2022-02-28 07464490 core:LandBuildings core:ShortLeaseholdAssets 2023-02-28 07464490 core:FurnitureFittingsToolsEquipment 2023-02-28 07464490 core:WithinOneYear 2023-02-28 07464490 core:WithinOneYear 2022-02-28 07464490 core:AfterOneYear 2023-02-28 07464490 core:AfterOneYear 2022-02-28 07464490 core:ShareCapital 2023-02-28 07464490 core:ShareCapital 2022-02-28 07464490 core:RetainedEarningsAccumulatedLosses 2023-02-28 07464490 core:RetainedEarningsAccumulatedLosses 2022-02-28 07464490 core:BetweenOneFiveYears 2023-02-28 07464490 core:BetweenOneFiveYears 2022-02-28 07464490 core:MoreThanFiveYears 2023-02-28 07464490 core:MoreThanFiveYears 2022-02-28 07464490 core:LandBuildings core:ShortLeaseholdAssets 2022-03-01 2023-02-28 07464490 core:NetGoodwill 2022-02-28 07464490 core:LandBuildings core:ShortLeaseholdAssets 2022-02-28 07464490 core:FurnitureFittingsToolsEquipment 2022-02-28 07464490 bus:SmallEntities 2022-03-01 2023-02-28 07464490 bus:AuditExemptWithAccountantsReport 2022-03-01 2023-02-28 07464490 bus:FullAccounts 2022-03-01 2023-02-28 07464490 bus:SmallCompaniesRegimeForAccounts 2022-03-01 2023-02-28 07464490 bus:PrivateLimitedCompanyLtd 2022-03-01 2023-02-28 07464490 core:WithinOneYear 2022-03-01 2023-02-28 07464490 core:AfterOneYear 2022-03-01 2023-02-28 07464490 core:OtherRelatedParties core:OtherTransactionType1 2022-03-01 2023-02-28
Company registration number: 07464490
Aarjay Healthcare Limited
Unaudited filleted financial statements
28 February 2023
Aarjay Healthcare Limited
Contents
Statement of financial position
Notes to the financial statements
Aarjay Healthcare Limited
Statement of financial position
28 February 2023
2023 2022
Note £ £ £ £
Fixed assets
Intangible assets 5 211,495 317,243
Tangible assets 6 34,731 33,663
_______ _______
246,226 350,906
Current assets
Stocks 125,581 127,896
Debtors 7 626,547 395,699
Cash at bank and in hand 9,761 70,541
_______ _______
761,889 594,136
Creditors: amounts falling due
within one year 8 ( 467,916) ( 447,438)
_______ _______
Net current assets 293,973 146,698
_______ _______
Total assets less current liabilities 540,199 497,604
Creditors: amounts falling due
after more than one year 9 ( 308,055) ( 38,570)
_______ _______
Net assets 232,144 459,034
_______ _______
Capital and reserves
Called up share capital 476,023 476,023
Profit and loss account ( 243,879) ( 16,989)
_______ _______
Shareholders funds 232,144 459,034
_______ _______
For the year ending 28 February 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476;
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of comprehensive income has not been delivered.
These financial statements were approved by the board of directors and authorised for issue on 23 November 2023 , and are signed on behalf of the board by:
Mr Jayantkumar Doshi
Director
Company registration number: 07464490
Aarjay Healthcare Limited
Notes to the financial statements
Year ended 28 February 2023
1. General information
The company is a private company limited by shares, registered in England & Wales. The address of the registered office is Scottish Provident House, 3rd Floor, 76 - 80 College Road, Harrow, Middlesex, HA1 1BQ. The principal activity of the company is that of dispensing chemists and wholesalers of pharmaceutical products.
2. Statement of compliance
These financial statements have been prepared in compliance with the provisions of FRS 102, Section 1A, 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and Companies Act 2006.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis.The financial statements are prepared in sterling, which is the functional currency of the entity.
Going concern
In accordance with their responsibilities as directors, the directors have considered the appropriateness of the going concern basis for the preparation of the financial statements.The directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus the directors continue to adopt the going concern basis of accounting in preparing the financial statements.
Turnover
Turnover is measured at the fair value of the consideration received or receivable for goods supplied and services rendered, net of discounts and Value Added Tax.
Revenue from the sale of goods is recognised when the significant risks and rewards of ownership have transferred to the buyer (usually on despatch of the goods); the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity; and the costs incurred or to be incurred in respect of the transactions can be measured reliably.
Taxation
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in the statement of comprehensive income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves. In this case, tax is recognised in other comprehensive income or directly in capital and reserves, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.
Operating leases
Lease payments are recognised as an expense over the lease term on a straight-line basis. The aggregate benefit of lease incentives is recognised as a reduction to expense over the lease term, on a straight-line basis.
Goodwill
Goodwill arises on business acquisitions and represents the excess of the cost of the acquisition over the company's interest in the net amount of the identifiable assets, liabilities and contingent liabilities of the acquired business. Goodwill is measured at cost less accumulated amortisation and accumulated impairment losses. It is amortised on a straight line basis over its useful life. Where a reliable estimate of the useful life of goodwill or intangible assets cannot be made, the life is presumed not to exceed ten years.
Amortisation
Amortisation is calculated so as to write off the cost of an asset, less its estimated residual value, over the useful life of that asset as follows:
Goodwill - Over 14 years
If there is a further indication that there has been a significant change in the amortisation rate, useful life or residual value of an intangible asset the amortisation is revised prospectively to reflect the new estimates.
Tangible assets
Tangible assets are initially recorded at cost, and is subsequently stated at cost less any accumulated depreciation and any accumulated impairment losses.
Depreciation
Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:
Short leasehold property - over the life of the lease
Fittings fixtures and equipment - 15 % reducing balance
If there is an indication that there has been a significant change in depreciation rate, useful life or residual value of tangible assets, the depreciation is revised prospectively to reflect the new estimates.
Impairment
A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date. When it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that are largely independent of the cash inflows from other assets or groups of assets. For impairment testing of goodwill, the goodwill acquired in a business combination is, from the acquisition date, allocated to each of the cash-generating units that are expected to benefit from the synergies of the combination, irrespective of whether other assets or liabilities of the company are assigned to those units.
Stocks
Stocks are measured at the lower of cost, using first in first out method, and estimated selling price less costs to complete and sell. Cost included all costs of purchase, costs of conversion and other costs incurred in bringing the stocks to their present location and condition.
Government grants
Under the accrual model, government grants relating to revenue are recognised on a systematic basis over the periods in which the company recognises the related costs for which the grant is intended to compensate. Grants that are receivable as compensation for expenses or losses already incurred or for the purpose of giving immediate financial support to the entity with no future related costs are recognised in income in the period in which it becomes receivable.
Financial instruments
A financial asset or a financial liability is recognised only when the company becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Debt instruments are subsequently measured at amortised cost. Where investments in non-convertible preference shares and non-puttable ordinary shares or preference shares are publicly traded or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value with changes in fair value recognised in profit or loss. All other such investments are subsequently measured at cost less impairment. Other financial instruments, including derivatives, are initially recognised at fair value, unless payment for an asset is deferred beyond normal business terms or financed at a rate of interest that is not a market rate, in which case the asset is measured at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Other financial instruments are subsequently measured at fair value, with any changes recognised in profit or loss, with the exception of hedging instruments in a designated hedging relationship.
Financial assets that are measured at cost or amortised cost are reviewed for objective evidence of impairment at the end of each reporting date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately. For all equity instruments regardless of significance, and other financial assets that are individually significant, these are assessed individually for impairment. Other financial assets or either assessed individually or grouped on the basis of similar credit risk characteristics. Any reversals of impairment are recognised in profit or loss immediately, to the extent that the reversal does not result in a carrying amount of the financial asset that exceeds what the carrying amount would have been had the impairment not previously been recognised.
Defined contribution plans
The pension costs charged in the financial statements represent the contribution payable by the company during the year.
4. Employee numbers
The average number of persons employed by the company during the year amounted to 13 (2022: 13 ).
5. Intangible assets
Goodwill Total
£ £
Cost
At 1 March 2022 and 28 February 2023 961,340 961,340
_______ _______
Amortisation
At 1 March 2022 644,097 644,097
Charge for the year 105,748 105,748
_______ _______
At 28 February 2023 749,845 749,845
_______ _______
Carrying amount
At 28 February 2023 211,495 211,495
_______ _______
At 28 February 2022 317,243 317,243
_______ _______
6. Tangible assets
Short leasehold property Fixtures, fittings and equipment Total
£ £ £
Cost
At 1 March 2022 8,202 144,291 152,493
Additions 4,633 1,897 6,530
_______ _______ _______
At 28 February 2023 12,835 146,188 159,023
_______ _______ _______
Depreciation
At 1 March 2022 6,754 112,076 118,830
Charge for the year 473 4,989 5,462
_______ _______ _______
At 28 February 2023 7,227 117,065 124,292
_______ _______ _______
Carrying amount
At 28 February 2023 5,608 29,123 34,731
_______ _______ _______
At 28 February 2022 1,448 32,215 33,663
_______ _______ _______
7. Debtors
2023 2022
£ £
Trade debtors 130,103 131,419
Other debtors 496,444 264,280
_______ _______
626,547 395,699
_______ _______
Included within other debtors are amounts owed by a connected company of £438,259 (2022: £221,286), which are unsecured, interest bearing at 3.5% Per annum and repayable on 7 February 2026.
8. Creditors: amounts falling due within one year
2023 2022
£ £
Bank loans and overdrafts (Note 9.) 36,630 69,928
Trade creditors 287,113 312,543
Corporation tax 2 2
Social security and other taxes 17,189 16,737
Other creditors 126,982 48,228
_______ _______
467,916 447,438
_______ _______
Other creditors includes an unsecured Bounce Back Loan of £10,648 (2022: £10,648), which is interest bearing at 2.5% P.A.and is repayable in Janaury 2026.
9. Creditors: amounts falling due after more than one year
2023 2022
£ £
Bank loans and overdrafts 279,012 -
Other creditors 29,043 38,570
_______ _______
308,055 38,570
_______ _______
The bank loan and overdraft are secured by first legal charge over the company's leasehold properties and debenture over all its assets and undertakings. The bank loan was repaid in May 2022.
Other creditors represents an unsecured Bounce Back Loan of £29,043 (2022: 38,570), which is interest bearing at 2.5% P.A.and is repayable in Janaury 2026.
10. Operating leases
The company as lessee
The total future minimum lease payments under non-cancellable operating leases are as follows:
£ £
Not later than 1 year 30,840 32,470
Later than 1 year and not later than 5 years 103,800 108,690
Later than 5 years 55,533 81,483
_______ _______
190,173 222,643
_______ _______
11. Related party transactions
During the year consultancy fees amounting to £31,500 (2022: £38,300) were paid to connected company.